Nocimed is now Aclarion.

AUTHOR: Jodi

Aclarion Announces Start of Healthcare Economic Analysis Study to Evaluate Financial Impact of Nociscan

Initial findings from the EVAL study are expected to be released in Q4 2022 Study initiated to assess impact of Nociscan on the cost of care for chronic low back pain (CLBP) patients Promising initial clinical evaluations with 87% of patients treated at discs identified as painful by Nociscan continuing to show significant clinical improvements […]

Request Info or Schedule a Demo

"*" indicates required fields

This field is for validation purposes and should be left unchanged.

Aclarion
8181 Arista Place,
Suite 100
Broomfield, CO 80021

info@aclarion.com

(800) 535-6302